Detalhe da pesquisa
1.
PCSK9 Inhibitors in Secondary Prevention-An Opportunity for Personalized Therapy.
J Cardiovasc Pharmacol
; 75(5): 410-420, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32379108
2.
You don't need a title to lead.
J Am Pharm Assoc (2003)
; 57(1): 7-8, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28038702
3.
Lesinurad, a Selective URAT-1 Inhibitor With a Novel Mechanism in Combination With a Xanthine Oxidase Inhibitor, for Hyperuricemia Associated With Gout.
J Pharm Pract
; : 897190017734427, 2017 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28980503